UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 122 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$223,946
-58.0%
94,0950.0%0.00%
Q2 2023$533,5190.0%94,0950.0%0.00%
Q1 2023$533,519
+15.7%
94,095
+14.2%
0.00%
Q4 2022$461,233
-99.9%
82,3630.0%0.00%
Q3 2022$528,770,000
+54.0%
82,363
-17.7%
0.00%
Q2 2022$343,247,000
-40.2%
100,072
+24.1%
0.00%
Q1 2022$574,315,000
-14.5%
80,662
+0.1%
0.00%
Q4 2021$671,515,000
-77.6%
80,614
-81.3%
0.00%
-100.0%
Q3 2021$2,997,664,000
+39.6%
430,699
+378.2%
0.00%0.0%
Q2 2021$2,148,027,000
+44.8%
90,064
+25.0%
0.00%0.0%
Q1 2021$1,483,056,000
-4.0%
72,028
+14.3%
0.00%0.0%
Q4 2020$1,544,334,000
+2035.2%
63,034
+498.7%
0.00%
Q1 2019$72,327,000
+4299.5%
10,528
-92.1%
0.00%
-100.0%
Q3 2016$1,644,000
-60.8%
133,727
-7.3%
0.00%
-60.0%
Q2 2016$4,193,000
+78.3%
144,323
+63.0%
0.01%
+66.7%
Q1 2016$2,352,000
-23.0%
88,551
+1.8%
0.00%0.0%
Q4 2015$3,054,000
+8.0%
87,021
-8.8%
0.00%0.0%
Q3 2015$2,829,000
-0.0%
95,445
+39.9%
0.00%0.0%
Q2 2015$2,830,00068,2000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$131,073,6455.09%
Lion Point Capital, LP 596,803$3,383,8731.39%
Eversept Partners, LP 2,536,665$14,382,8911.00%
Knott David M Jr 315,000$1,7860.70%
Kynam Capital Management, LP 768,913$4,359,7370.56%
SILVERARC CAPITAL MANAGEMENT, LLC 232,525$1,318,4170.54%
Simplify Asset Management Inc. 550,626$3,122,0490.45%
Atom Investors LP 90,388$512,5000.28%
FEDERATED HERMES, INC. 15,277,356$86,622,6090.22%
IRONWOOD INVESTMENT MANAGEMENT LLC 47,796$271,0030.17%
View complete list of SERES THERAPEUTICS INC shareholders